Clinical Trials Browser

Phase NA × Leukemia, B-Cell × Immunotherapy, Adoptive × Clear all

NCT06355739 2024-04-09

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma